Evidence map›Paper›PMID 41460381›Full record

ReviewNeurochemical research2025

Regulatory Landscapes of Protein Acylations in Neuroinflammation: From Molecular Mechanisms to Therapeutic Targets.

Jinxuan Han, Jingjing Han, Shuangshuang Duan, Chunlei Xin, Pei Jiang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jinxuan HanSchool of Clinical Medicine, Shandong Second Medical University, Weifang, 261053, China.
Jingjing HanDepartment of Hematology, Jining First People's Hospital, Shandong First Medical University, No. 6 Jiankang Road, Jining, 272000, China.
Shuangshuang DuanDepartment of Hematology, Jining First People's Hospital, Shandong First Medical University, No. 6 Jiankang Road, Jining, 272000, China.
Chunlei XinDepartment of Hematology, Jining First People's Hospital, Shandong First Medical University, No. 6 Jiankang Road, Jining, 272000, China. xinchunlei28@163.com.
Pei JiangTranslational Pharmaceutical Laboratory, Jining First People's Hospital, Shandong First Medical University, No. 6 Jiankang Road, 272000, Jining, China. jiangpeicsu@sina.com.

Funding

Joint TCM Science & Technology Projects of National Demonstration Zones for Comprehensive TCM Reform GZY-KJS-SD-2024-021the National Natural Science Foundation of China 82571575the Natural Science Foundation of Shandong Province ZR2024YQ074
6 · The paper itself

Abstract

In recent years, the role of novel protein acylation modifications in neuroinflammation has gradually become a hot research topic. In this paper, we reviewed the molecular mechanisms of five types of acylation modifications, namely lactylation (Kla), succinylation (Ksucc), crotonylation (Kcr), β-hydroxybutyrylation (Kbhb) and palmitoylation, and their association with neuroinflammation. To clarify the roles of these acylation modifications in neuroinflammation, we summarized the acyl donors, key regulatory enzymes (acyltransferases and deacylases), and dynamic regulatory networks for each modification type. On the one hand, they are directly involved in the inflammatory response by regulating microglial activation and pro-inflammatory factor release; on the other hand, they can indirectly affect the neurodegenerative disease process through metabolic reprogramming. This article also discusses drug development for novel acylases, including strategies based on enzyme activity inhibition or metabolic intervention, and points out the limitations of current studies. Future studies need to explore the spatial and temporal dynamics of acylation modifications, cross-regulatory networks and their functions in the neuroimmune microenvironment to provide new targets for the development of precise anti-neuroinflammatory therapies. The discovery of novel acylation modifications not only expands the theoretical framework of protein post-translational modification (PTM), but also opens up a multi-dimensional intervention pathway for the treatment of neuroinflammation-related diseases.

Indexed as

Neuroinflammatory DiseasesProtein Processing, Post-TranslationalAcylationAcyltransferasesAnimalsHumansAcyltransferasesCrotonylationLactylationNeuroinflammationPalmitoylationSuccinylationΒ-hydroxybutyrylation

Identifiers

PMID41460381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.